Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Ricardo Menegatti | Pharmaceutical Science | Best Researcher Award

Associate Professor and UFG, Brazil

Assoc. Prof. Dr. Ricardo Menegatti is an Associate Professor at the Faculty of Pharmacy, Federal University of Goiás (UFG), Brazil. His academic journey began with a Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC), followed by a Master’s degree in Chemistry and a Ph.D. in Chemistry from the Federal University of Rio de Janeiro (UFRJ). His doctoral research focused on the design, synthesis, and pharmacological evaluation of novel neuroactive drug prototypes. Dr. Menegatti’s expertise spans various aspects of medicinal chemistry, including the development of new pharmacological agents, medicinal chemistry, and pharmaceutical analysis. He has been actively involved in teaching and research since joining UFG in 2006, where he has contributed to the development of courses in medicinal chemistry, pharmaceutical analysis, and organic chemistry. His work also includes extensive contributions to the university’s extension activities, such as coordinating workshops and seminars on pharmaceutical chemistry. Dr. Menegatti has a robust record of publications and presentations in his field, and his research interests primarily revolve around the synthesis of novel pharmacological agents and the application of advanced chemical techniques in drug development.

Profile
Education

Dr. Ricardo Menegatti holds a distinguished educational background in the field of pharmacy and chemistry. He earned his Bachelor’s degree in Pharmacy from the Federal University of Santa Catarina (UFSC) in 1998, where his research focused on leprosy. He then pursued advanced studies at the Federal University of Rio de Janeiro (UFRJ), obtaining a Master’s degree in Chemistry in 2001. His master’s research, under the guidance of Eliezer Jesus Barreiro, involved the design, synthesis, and pharmacological evaluation of new antipsychotic drug candidates, specifically targeting schizophrenia. Dr. Menegatti further advanced his expertise by completing a Ph.D. in Chemistry at UFRJ in 2005, focusing on the planning, synthesis, and pharmacological assessment of neuroactive drug prototypes, particularly in the areas of GABA, hypnotics, and analgesics. His doctoral research, also mentored by Eliezer J. Barreiro, was supported by the National Council for Scientific and Technological Development (CNPq), reflecting his commitment to advancing pharmaceutical sciences.

Professional Experience

Dr. Ricardo Menegatti is a seasoned academic and researcher with a strong background in pharmaceutical chemistry and medicinal compounds. He holds a Doctorate in Chemistry from the Federal University of Rio de Janeiro, where his research focused on the design, synthesis, and pharmacological evaluation of neuroactive drug prototypes. Dr. Menegatti currently serves as a Professor at the Faculty of Pharmacy, Federal University of Goiás, Brazil, where he has been a dedicated faculty member since 2006. His expertise lies in planning and synthesizing biologically active compounds, particularly those targeting neuroactive and antipsychotic pathways. In addition to his teaching responsibilities, Dr. Menegatti is actively involved in graduate-level mentoring, guiding students in the Biological Sciences postgraduate program. His contributions extend to organizing workshops, coordinating seminars, and participating in extension activities, reflecting his commitment to advancing pharmaceutical education and research.

Research Interests

Dr. Ricardo Menegatti’s research interests lie at the intersection of pharmaceutical chemistry and medicinal chemistry, with a particular focus on the design, synthesis, and pharmacological evaluation of biologically active compounds. His work primarily revolves around the development of neuroactive drug prototypes, targeting the GABAergic system to explore potential treatments for neurological disorders such as schizophrenia, anxiety, and sleep disorders. Additionally, Dr. Menegatti is engaged in the discovery of new analgesic and antipsychotic agents, leveraging his expertise in molecular modeling and structure-activity relationships (SAR) to enhance drug efficacy and safety. His research also extends to the use of solid-phase synthesis and enzymatic catalysis in drug development, aiming to innovate in the creation of new therapeutic agents. Through his work, Dr. Menegatti contributes to the advancement of medicinal chemistry, striving to address critical challenges in the treatment of mental health disorders.

Awards and Recognition

Dr. Menegatti’s academic and research excellence has been recognized through various awards and honors throughout his career. As a recipient of scholarships from the National Council for Scientific and Technological Development (CNPq) in Brazil, he has demonstrated a strong commitment to advancing scientific knowledge. His leadership in organizing workshops and seminars further highlights his contributions to the academic community, earning him recognition among his peers and students.

Conclusion

Dr. Ricardo Menegatti’s extensive research contributions in medicinal chemistry, particularly in the development of neuroactive and antipsychotic drug candidates, make him a strong candidate for the Research for Best Researcher Award. His work has a significant geographic impact, with potential applications in global healthcare. While his research is primarily focused on pharmaceutical sciences, its implications extend to broader areas such as infectious diseases. Dr. Menegatti’s collaborative efforts, applied research, and academic leadership further solidify his suitability for this prestigious award.

Publications Top Notes

LQFM289: Electrochemical and Computational Studies of a New Trimetozine Analogue for Anxiety Treatment

  • Journal: International Journal of Molecular Sciences
  • Date: September 26, 2023
  • DOI: 10.3390/ijms241914575

Bioanalytical LC-QTOF/MS Method for a N-phenylpiperazine Derivate (LQFM05): An Anxiolytic- and Antidepressant-like Prototype Drug Applied to Pharmacokinetic and Biodistribution Studies

Antileishmanial Activity of the Chalcone Derivative LQFM064 Associated with Reduced Fluidity in the Parasite Membrane as Assessed by EPR Spectroscopy

Toxico-Pharmacological Evaluations of the Small-Molecule LQFM166: Inducer of Apoptosis and MDM2 Antagonist

 

Assoc Prof Dr. Yuzhu Tan | Pharmaceutical Resources | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Yuzhu Tan | Pharmaceutical Resources | Best Researcher Award

Assistant Professor at Pharmaceutical Resources ,Chengdu University of Traditional Chinese Medicine, China

👨‍🎓He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Assoc. Prof. Dr. Yuzhu Tan has an extensive academic background in Traditional Chinese Medicine (TCM), with a focus on research and development. He completed his Bachelor of Arts in Traditional Chinese Medicine at Hubei University for Nationalities in Enshi, PR China, from September 2005 to June 2009. He furthered his studies by obtaining a Master of Arts in Chemistry of Chinese Materia Medica at Chengdu University of Traditional Chinese Medicine from September 2009 to June 2012. Dr. Tan pursued his Ph.D. in Chinese Materia Medica at Chengdu University of Traditional Chinese Medicine from September 2013 to June 2017, focusing on the study of the chemical constituents of Valeriana jatamansi Jones and their biological activities. Subsequently, he engaged in joint postdoctoral training at Chengdu University of Traditional Chinese Medicine and Sichuan NewGreenMedicine Science and Technology Development Co., Ltd., Chengdu, PR China, from January 2018 to January 2021. His postdoctoral research involved quality evaluation on the stem and leaf of Ligusticum chuanxiong Hort and the discovery of vasodilatory active components. Dr. Tan’s academic journey reflects his dedication to advancing the understanding and application of Traditional Chinese Medicine through rigorous scientific research and analysis.

Research Funding:

Assoc Prof Dr. Yuzhu Tan has received notable funding and recognition for his work in the field of science and technology. In 2021, he was awarded the Outstanding Youth Science Fund Project of Sichuan Province (project number 2021JDJQ0040). Additionally, he has received support from the National Natural Science Foundation of China, with grant numbers 81703693 and 82373837, as well as the China Postdoctoral Science Foundation under project number 2019M653363. Dr. Tan’s research has also been funded by the Fund Project of Science and Technology of Sichuan (project number 2019052), the Key Fund Project for the Education Department of Sichuan (project number 17ZB0156), and the Chengdu Municipal Science and Technology Foundation (project number 2016-HM01-00457-SF). These grants and projects reflect his commitment to advancing scientific knowledge and his contributions to the field of science and technology.

Award & Honors:

Assoc. Prof. Dr. Yuzhu Tan has been recognized for his outstanding contributions and achievements in the field of pharmaceutical sciences. Notable accolades include his participation as an Outstanding Student in the Training Course for Analysis and Application of Organic Mass Spectrometry held in Beijing, China, from May 16-19, 2017. He was also recognized as an Outstanding Student in the National Chinese Medicine Chemistry Training Course for the Young and Middle-aged Key Teachers, organized by the Higher Pharmacy Education Advisory Board under the Ministry of Education, held in Harbin, China, from July 23-27, 2017. Dr. Tan received the First Prize of Innovation Achievement and Excellent Paper Award at the 2016 International Forum of Pharmacy Students and 9th National Pharmaceutical Circles Forum, where he served as an Instructor at the China Pharmaceutical University, Nanjing, China, on November 8-9, 2016. Additionally, he was honored with the Third Prize of Conference Paper at The Fifth Annual Academic Conference of the Association of World Institutes of Traditional Chinese Medicine, held in Inner Mongolia, China, from July 20-22, 2016. Dr. Tan’s dedication to advancing pharmaceutical education and research is evident through his active participation and notable achievements in various national and international forums and conferences.

Publications:

Unlocking the hidden potential: Enhancing the utilization of stems and leaves through metabolite analysis and toxicity assessment of various parts of Aconitum carmichaelii

Interactions between gut microbiota and polyphenols: A mechanistic and metabolomic review

Therapeutic Effects of Valeriana jatamansi on Ulcerative Colitis: Insights into Mechanisms of Action through Metabolomics and Microbiome Analysis

Polyethylene glycol functionalized Fe3O4@MIL-101(Cr) for the efficient removal of heavy metals from Ligusticum chuanxiong Hort

Diverse alkaloids from the aerial parts of Aconitum carmichaelii and antiproliferative activity of costemline via inhibiting SIRT1/ROCK1/P-STAT3 pathways

Atractylodes macrocephala Koidz. volatile oil relieves acute ulcerative colitis via regulating gut microbiota and gut microbiota metabolism

Lignans from the root of Valeriana jatamansi and their biological evaluation

Review of lignans from 2019 to 2021: Newly reported compounds, diverse activities, structure-activity relationships and clinical applications

Interactions between polysaccharides and gut microbiota: A metabolomic and microbial review

Ajuforrestin A, an Abietane Diterpenoid from Ajuga ovalifolia var. calanthe, Induces A549 Cell Apoptosis by Targeting SHP2

 

Assist Prof Dr. Amjad Khan | Pharmacy | Best Researcher Award

Posted on by ScienceFather

Assist Prof Dr. Amjad Khan | Pharmacy | Best Researcher Award

Assistant Professor at Quaid-i-Azam University, Pakistan

👨‍🎓He remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 He successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Academic Record:

Assistant Professor Dr. Amjad Khan has a remarkable academic background, including a Ph.D. in Clinical Pharmacy from the School of Pharmaceutical Sciences, Universiti Sains Malaysia (USM), Malaysia, awarded in 2019. His doctoral thesis was titled “Evaluation of time to achieve Dry Weight using Body Composition Monitor, Hypertension management and prevalence of Depression among Hemodialysis patients in Kelantan Malaysia.” Additionally, he holds an M.Phil. in Pharmaceutical Biotechnology from the Department of Biotechnology, Quaid-i-Azam University, Pakistan, completed in 2014, focusing on the isolation, structure elucidation, and biological activities of Acridocarpus Orientalis A. Juss. Furthermore, Dr. Khan achieved his Doctor of Pharmacy (Pharm.D.) from Gomal University, Pakistan, graduating with distinction (Gold Medal award) from the Faculty of Pharmacy in 2012, with an impressive percentage of 81% (A Grade). His earlier educational achievements include F. Sc (Pre-Medical) from BISE D.I.Khan, KP, Pakistan, in 2007, and S.S.C. (Science) from BISE Bannu, KP, Pakistan, in 2005.

Research Interest:

Assistant Professor Dr. Amjad Khan’s expertise spans several key areas within the field of healthcare. With a focus on infectious diseases, his knowledge and experience are invaluable in understanding and combating various infectious agents and their impact on public health. Additionally, his specialization in nephrology enables him to contribute significantly to the study and treatment of kidney-related conditions, particularly in the context of infectious diseases.

Professional Experience:

Assistant Professor Dr. Amjad Khan has been an integral part of the Department of Pharmacy at Quaid-i-Azam University in Islamabad, Pakistan, holding various academic positions:

  1. Assistant Professor (TTS), Department of Pharmacy Duration: From 22nd October 2019 to present.
  2. Assistant Professor (BPS), Department of Pharmacy Duration: From 12th June 2019 to 21st October 2019.
  3. Lecturer in Clinical Pharmacy, Department of Pharmacy Duration: From 27th April 2017 to 11th June 2019.

Administrative & Academic Assignment:

Dr. Amjad Khan has been actively involved in various academic and administrative roles at Quaid-i-Azam University, Islamabad, contributing to the development and management of educational processes and initiatives. His roles include:

  • Member of the Departmental Admission Committee for Undergraduate (Pharm.D.) Programs at Quaid-i-Azam University, Islamabad, since September 19, 2022.
  • WHO/EPI Polio Campaigns Focal Person for the Pharmacy Department at Quaid-i-Azam University, Islamabad, since August 17, 2022.
  • Member of the Teaching Evaluation Committee at Quaid-i-Azam University, Islamabad, since June 22, 2022.
  • Focal Person for the Higher Education Data Repository (HEDR) at Quaid-i-Azam University, Islamabad, since May 30, 2022.
  • Member of the Departmental Attendance Committee at Quaid-i-Azam University, Islamabad, since April 25, 2022.

Award & Honors:

  • Quaid-i-Azam University Best Performance Award for the year 2022-2023.
  • Gold Medal and Merit Certificate from Gomal University for securing First-Class First-Position in the Doctor of Pharmacy (Pharm.D.) Degree, Session (2007-2012).
  • Continuous Merit Scholarship throughout his Pharmacy Career.
  • Approval as an international supervisor by the University of Oslo, Norway; The University of Edinburgh, UK; and Universiti Sains Malaysia (USM), Malaysia, for assisting/co-supervising research students.
  • Six Months Research Fellowship at UoN Chair of Oman’s Medicinal Plants and Marine Natural Products, funded by the University of Nizwa, Sultanate of Oman.
  • Participation in the Prime Minister’s Fee Reimbursement and Laptop Distribution Scheme to facilitate talented graduates in improving Higher Education during the academic year 2013-14.

Publications:

From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS)

  • Published in Energy in 2017 with 126 citations.

Prevalence and predictors of depression among hemodialysis patients: a prospective follow-up study

  • Published in Energy in 2019 with 91 citations.

COVID‐19 vaccinations: The unknowns, challenges, and hopes

  • Published in Energy in 2022 with 86 citations.

Structural elucidation and bioassays of newly synthesized pentavalent antimony complexes

  • Published in Energy in 2017 with 47 citations.

Health-related quality of life and its predictors among adults living with HIV/AIDS and receiving antiretroviral therapy in Pakistan

  • Published in Energy in 2021 with 45 citations.

Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa

  • Published in Energy in 2017 with 36 citations.

Seimatoric acid and colletonoic acid: Two new compounds from the endophytic fungi, Seimatosporium sp. and Colletotrichum sp.

  • Published in Energy in 2014 with 30 citations.

Management of patient care in hemodialysis while focusing on cardiovascular disease events and the atypical role of hyper-and/or hypotension: a systematic review

  • Published in Energy in 2016 with 28 citations.

 

 

Dr. Mihaela Tanase-Opedal | Chemical Engineering | Best Researcher Award

Posted on by ScienceFather

Dr. Mihaela Tanase-Opedal | Chemical Engineering | Best Researcher Award

Senior Researcher at Chemical Engineering, RISE PFI AS, Norway

👨‍🎓She remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 She successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

Dr. Mihaela Tanase-Opedal completed her Ph.D. in 2011 with a dissertation titled “Extractives in process water from compressive pre-treatment of chips in mechanical pulping” at the Department of Chemical Engineering, Faculty of Natural Science and Technology (NTNU) in Norway. Her disputation date was on 30.03.2011. Prior to this, in 2006, she pursued a study on “Methods of consolidation, conservation, and restoration of documents on paper support” at the Faculty of Chemical Engineering and Environmental Protection, “Gh. Asachi” Technical University Iasi, Romania.

Position:

Dr. Mihaela Tanase-Opedal has held various positions in research and science. Since 2020, she has been working as a Senior Research Scientist at RISE PFI in Trondheim, Norway. Prior to this role, she worked at the same institution as a Research Scientist from 2011 to 2020. Additionally, in June 2008, she took on a summer job at Norske Skog Saugbrugs Halden in Norway, where she was involved in a project focusing on mechanical bleaching.

Experience:

From 2021 to 2024, she served as the Work Package (WP) leader for the project titled “Green wax inhibitors and production chemicals based on lignin (LignoWax),” funded by the Research Council of Norway. In the same period (2021-2023), she took on the role of Project Leader for a preliminary study focused on the optimal recovery of chemicals from process water. This project was owned by Rygene Smith&Thommesen AS and received funding from Innovation Norway. In another project from 2021 to 2022, she led a WP for the project “Bærekraftig fiskefôr fra norsk skogbasert biomasse (FôrNor),” which was an IPN project (321588). In this project, she was both the Project Leader and the project owner, representing Synergifabrikken AS. RISE PFI participated in this project as a partner and was also a WP leader. Continuing her active involvement, from 2020 to 2024, Dr. Mihaela Tanase-Opedal acted as the WP leader for the project “Produksjon av Arbacore pellets and fôrprotein fra trevirke (ArbaFeed),” which was another IPN project (ES656466). In this project, she served as both the Project Leader and the project owner for Arbaflame, with RISE PFI participating as a partner and WP leader. In 2020-2022, she led the “FISK” project, part of the EU Project-Interreg Sverige-Norge.

 

Dr. Mohd Akbar Dar | Pharmaceutical Chemistry

Posted on by ScienceFather
Dr. Mohd Akbar Dar : Leading Researcher in Pharmaceutical Chemistry by Best Researcher Award

Assistant Professor at Pharmaceutical Chemistry, University of Kashmir, India

Your remarkable academic journey, extensive research contributions, and dedication to the field of psychology are truly commendable. Your wealth of knowledge and diverse skill set reflect a deep commitment to understanding and addressing critical issues such as bullying, inclusion, and socialization.

🔬 Your successful completion of a PhD in Psychology, along with the numerous advanced courses and workshops, showcases your continuous pursuit of excellence and expertise in your field.

🏆 The awards and recognitions, including the First Place in the Poster Award at the University of Stavanger, underscore the impact of your research and the high regard it holds in the academic community.

Professional Profiles:

Education:

The user has a Ph.D. in Pharmaceutical Chemistry from the Department of Pharmaceutical Sciences, University of Kashmir, obtained in 2018. They also hold an M. Pharm in Pharmaceutical Chemistry from the same university, earned in 2012 with a score of 78%. Additionally, they have a B. Pharm from the Department of Pharmaceutical Sciences, University of Kashmir, completed in 2008 with a score of 62%, and a B.Sc from Govt. Degree College Bemina, Srinagar, University of Kashmir, completed in 2005 with a score of 55%.

Work Experience:

The user has a diverse range of professional experiences in the pharmaceutical field, including a year as a Trainee Executive in Analytical and Production Division at Medley Pharmaceuticals Ltd. in Jammu, J&K, India, and a year as a Guest Lecturer at Tahira Khanam Paramedical Institute, Lawaypora, Srinagar, Kashmir. They have also been teaching B.Pharma (Pharm. Inorganic Chemistry & Pharmaceutical Analysis) and M.Pharma (Drug Design) students at the Department of Pharmaceutical Sciences, University of Kashmir, for 4 years as a BSR-Fellow. Additionally, they have been providing research guidance to M.Pharma students at the same department for 4 years as a BSR-Fellow and have been serving as an Assistant Professor (Contractual) at the Department of Pharmaceutical Sciences, University of Kashmir, since January 2017, accumulating 6 years and 1 month in this role.

Mohd Akbar Dar ‘s citation metrics and indices from Google Scholar are as follows:

  • Cited by: All: 1007, Since 2018: 672
  • Citations: 1007 (All), 672 (Since 2018)
  • h-index: 16 (All), 15 (Since 2018)
  • i10-index: 18 (All), 17 (Since 2018)

These metrics showcase the impact of Dar ‘s work within the academic community, demonstrating the number of citations his publications have received and the influence of his research output.

Research Interest:                                                                                            

The user has experience in various aspects of natural product chemistry and pharmacology, including isolating and analyzing bioactive molecules using different separation techniques, solving spectra for structure elucidation, and evaluating pharmacological activities using in-vitro and animal models.

Awards:

The user achieved an All India Rank of 697 in the Graduate Pharmacy Aptitude Test (GPAT) in 2014. They also received the Basic Scientific Research (BSR) Fellowship from the University Grants Commission (UGC), New Delhi, India, serving as a Junior Research Fellow from May 15, 2013, to May 14, 2015, and as a Senior Research Fellow from May 15, 2015, to November 1, 2017.

Publications:

Effect of post-harvest calcium chloride dip treatment and gamma irradiation on storage quality and shelf-life extension of Red delicious apple

  • Published in Energy in 2012 with 109 citations.

Studies on enhancing the keeping quality of peach (Prunus persica Bausch) Cv. Elberta by gamma-irradiation

  • Published in Energy in 2008 with 81 citations.

Carboxymethyl Cellulose Coating and Low‐Dose Gamma Irradiation Improves Storage Quality and Shelf Life of Pear (Pyrus Communis L., Cv. Bartlett/William)

  • Published in Energy in 2010 with 77 citations.

Bioactive compounds and antioxidant activity of gamma irradiated sun dried apricots (Prunus armeniaca L.)

  • Published in Energy in 2013 with 68 citations.

Gamma irradiation induced enhancement of phenylalanine ammonia-lyase (PAL) and antioxidant activity in peach (Prunus persica Bausch, Cv. Elberta)

  • Published in Energy in 2010 with 67 citations.

Effect of edible coating and gamma irradiation on inhibition of mould growth and quality retention of strawberry during refrigerated storage

  • Published in Energy in 2012 with 65 citations.